Ronald J Leflein is a notable inventor based in East Hanover, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for respiratory conditions. With a total of 2 patents, his work has had a meaningful impact on the treatment of common ailments.

Latest Patents

Leflein's latest patents include innovative formulations aimed at providing symptomatic relief for various respiratory issues. One of his patents focuses on antitussive and antihistaminic compositions, specifically tannate compositions that consist of carbetapentane tannate and chlorpheniramine tannate. These compositions are effective when administered orally for the symptomatic relief of coryza associated with the common cold, sinusitis, allergic rhinitis, unproductive cough, and upper respiratory tract conditions. Another patent addresses antitussive, antihistaminic, and decongestant compositions, which include carbetapentane tannate, pyrilamine tannate, and phenylephrine tannate. These formulations are designed to provide relief for cough associated with respiratory tract conditions such as the common cold, bronchial asthma, and both acute and chronic bronchitis.

Career Highlights

Leflein is currently associated with Medpointe Healthcare Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing effective treatments that enhance patient care and comfort.

Collaborations

One of his notable coworkers is Alexander D D'Addio, with whom he has likely collaborated on various projects within the company.

Conclusion

Ronald J Leflein's contributions to the field of pharmaceuticals through his patents demonstrate his commitment to improving health outcomes for individuals suffering from respiratory conditions. His innovative work continues to pave the way for advancements in treatment options.